Tumors of the thymus;Tumeurs du thymus

EMC - Pneumologie

Volumn 2, Issue 1, 2005, Pages 33-48

  Perrotin, C ^a   Regnard J F ^a  

^a HÔTEL DIEU   (France)

Author keywords

Germ cell tumours; Lymphomas; Myasthenia; Thymoma; Thymus

Indexed keywords

EID: 32644439345     PISSN: 17624223     EISSN: 17624223     Source Type: Journal    
DOI: 10.1016/j.emcpn.2004.10.001     Document Type: Short Survey

References (76)

1. Rosai J, Sobin LH. Histological typing of tumours of the thymus. International histological classification of tumours. New York: Springer-Verlag; 1999.
2. Morgenthaler TI, Brown LR, Colby TV, Harper C, Coles D. Thymoma. Mayo Clin Proc 1993;68:1110-23.
3. Ruffié P, Gory-Delabaere G, Fervers B, Lehmann M, Regnard JF, Resbeut M. Standards, options et recommandations pour la prise en charge des patients atteints de tumeurs épithéliales du thymus. Bull Cancer 1999;86:365-84.
4. Bergh NP, Gatzinski P, Larsson S, Lundin P, Ridell B. Tumors of the thymus and thymic region: I. Clinicopathological studies on thymomas. Ann Thorac Surg 1978;25: 91-8.
5. Rosai J, Levine GD. Tumors of the thymus. In: Fumiger HI, editor. Atlas of Tumor Pathology. Fascicle 13, Series 2, Washington DC: Armed Forces Institute of Pathology; 1976.
6. Suster S, Rosai J. Thymic carcinoma. A clinicopathologic study of 60 cases. Cancer 1991;67:1025-32.
7. Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer 1981;48:2485-92.
8. Regnard JF, Magdeleinat P, Dromer C, Dulmet E, De Montpreville V, Levi JF, et al. Prognostic factors and long-term results after thymoma resection: a series of 307 patients. J Thorac Cardiovasc Surg 1996;112:376-84.
9. Wilkins Jr EW, Grillo HC, Scannell JG, Moncure AC, Mathisen DJ. Role of staging in prognosis and management of thymoma. Ann Thorac Surg 1991;51:888-92.
10. Monden Y, Nakahara K, Moka S, Nanjo S, Ohno K, Fujii Y, et al. Recurrence of thymoma: clinicopathological features, therapy, and prognosis. Ann Thorac Surg 1985;39: 165-9.
11. Maggi G, Casadio C, Cavallo A, Cianci R, Molinatti M, Ruffini E. Thymoma: results of 241 operated cases. Ann Thorac Surg 1991;51:152-6156.
12. Pescamona E, Rendina EA, Venuta F, D'Arcangelo E, Pagani M, Ricci C, et al. Analysis of prognostic factors and clinicopathological staging of thymoma. Ann Thorac Surg 1990;50:534-8.
13. Blumberg D, Port JL, Wecksler BJ, Delgado R, Rosai J, Bains MS, et al. Thymomas: a multivariate analysis of factors predincting survival. Ann Thorac Surg 1995;60:908-13.
14. Regnard JF, Zinzindohoue F, Magdeleinat P, Guibert L, Spaggiari L, Levasseur P. Results of Re-resection for Recurrent Thymomas. Ann Thorac Surg 1997;64:1593-8.
15. Kondo K, Monden Y, Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan. Ann Thorac Surg 2003;76:878-84.
16. Mangi AA, Wright CD, Allan JS, Wain JC, Donahue DM, Grillo HC, et al. Adjuvant radiation therapy for stage II thymoma. Ann Thorac Surg 2002;74:1033-7.
17. Singhal S, Shrager JB, Rosenthal DI, LiVolsi VA, Kaiser LR. Comparison of stages I-II thymoma treated by complete resection with or without adjuvant radiation. Ann Thorac Surg 2003;76:1635-41.
18. Ogawa K, Uno T, Toita T, Onishi H, Yoshida H, Kakinohana Y, et al. Postoperative radiotherapy for patients with completely resected thymoma: a multi-institutional, retrospective review of 103 patients. Cancer 2002;94: 1405-13.
19. Yagi K, Hirata T, Fukuse T, Yokomise H, Inui K, Ike O, et al. Surgical treatment of invasive thymoma, especially when superior vena cava is invaded. Ann Thorac Surg 1996;62: 521-4.
20. Roviaro G, Varoli F, Rebuffat C, Vergani C, Maciocco M, Scalambra SM, et al. Videothoracoscopic excision of mediastinal masses. Ann Thorac Surg 1994;58:1679-84.
21. Shamji F, Pearson FG, Todd TRJ, Ginsberg RJ, Ilves R, Cooper JD. Results of surgical treatment for thymoma. J Thorac Cardiovasc Surg 1984;87:43-7.
22. Moore KH, McKenzie PR, Kennedy CW, McCaughan BC. Thymomas: Trend Over Time. Ann Thorac Surg 2001;72: 203-7.
23. Chen G, Marx A, Wen-Hu C, Yong J, Puppe B, Stroebel P, et al. New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China. Cancer 2002;95:420-9.
24. Nakagawa K, Asamura H, Matsuno Y, Suzuki K, Kondo H, Maeshima A, et al. Thymoma: a clinicopathologic study based on the new World Health Organization classification. J Thorac Cardiovasc Surg 2003;126:1134-40.
25. Martinez LQ, Wilkins EW, Choi N, Efird J, Hug E, Harris NL. Thymoma: histologic subclassification is an independant prognostic factor. Cancer 1994;74:606-17.
26. Okurama M, Ohta M, Tateyama H, Nakagawa K, Matsumara A, Maeda H, et al. The World Health Organization Histologic Classification System Reflects the Oncologic Behavior of Thymoma. Cancer 2002;94:624-32.
27. Quintanilla-Martinez L, Wilkins Jr EW, Choi N, Efird J, Hug E, Harris NL. Thymoma. Histologic subclassification is an independent prognostic factor. Cancer 1994;74:606-17.
28. Verley JM, Hollmann KH. Thymoma. A comparative study of clinical stages, histologic features, and survival in 200 cases. Cancer 1985;55:1074-86.
29. Okumura M, Miyoshi S, Takeuchi Y, Yoon HE, Minami M, Takeda SI, et al. Results of surgical treatment of thymomas with special reference to the involved organs. J Thorac Cardiovasc Surg 1999;117:605-13.
30. Nakahara K, Ohno K, Hashimoto A, Maeda H, Miyoshi S, Sakurai M, et al. Thymoma: results with complete resection and adjuvant postoperative irradiation in141 patients. J Thorac Cardiovasc Surg 1988;95:1041-7.
31. Ruffini E, Mancuso M, Oliaro A, Casadio C, Cavallo A, Cianci R, et al. Recurrence of thymoma: analysis of clinicopathologic features, treatment and outcome. J Thorac Cardiovasc Surg 1997;113:55-63.
32. Kirschner PA. Reoperation on the thymus. A critique. Chest Surg Clin North Am 2001;11:439-45.
33. Loeher PJ, Kim KM, Aisner SC, Livingston R, Einhorn LH, Johnson D, et al. Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma. Final results of an intergroup trial. J Ctin Oncol 1994;12:1164-8.
34. Glaccone G, Ardizzoni A, Kirkpatrick A, Clerico M, Shamoud T, Van Zandwijk. Cisplatin and etoposide combination chemotherapy for locally avance or metastatic thymoma: a phase II study of the european organization for research and treatment of cancer lung cancer cooperative group. J Clin Oncol 1996;14:814-20.
35. Tseng YL, Wang ST, Wu MH, Lin MY, Lai WW, Cheng FF. Thymic carcinoma: involvement of great vessels indicates poor prognosis. Ann Thorac Surg 2003;76:1041-5.
36. Ogawa K, Toita T, Uno T, Fuwa N, Kakinohana Y, Kamata M, et al. Treatment and prognosis of thymic carcinoma: a retrospective analysis of 40 cases. Cancer 2002;94:3115-9.
37. Lucchi M, Mussi A, Ambrogi M, Gunfiotti A, Fontanini G, Basolo F, et al. Thymic carcinoma: a report of 13 cases. Eur J Surg Oncol 2001;27:636-40.
38. Chung DA. Thymic carcinoma-analysis of nineteen clinicopathological studies. Thorac Cardiovasc Surg 2000;48: 114-9.
39. Yoh K, Goto K, Ishii G, Niho S, Ohmatsu H, Kubota K, et al. Weekly chemotherapy with cisplatin, vincristine, doxorubicin, and etoposide is an effective treatment for advanced thymic carcinoma. Cancer 2003;98:926-31.
40. Liu HC, Hsu WH, Chen YJ, Chan YJ, Wu YC, Huang BS, et al. Primary thymic carcinoma. Ann Thorac Surg 2002;73:1076-81.
41. Chaer R, Massad MG, Evans A, Snow NJ, Geha AS. Primary neuroendocrine tumors of the thymus. Ann Thorac Surg 2002;74:1733-40.
42. Rosai J, Higa E. Mediastinal endocrine neoplasm, of probable thymic origin, related to carcinoid tumor. Clinicopathologic study of 8 cases. Cancer 1972;29:1061-74.
43. Tiffet O, Nicholson AG, Ladas G, Sheppard MN, Goldstraw P. A clinicopathologic study of 12 neuroendocrine tumors arising in the thymus. Chest 2003;124:141-6.
44. Moran CA, Suster S. Neuroendocrine carcinomas (carcinoid tumor) of the thymus. A clinicopathologic analysis of 80 cases. Am J Clin Pathol 2000;114:100-10.
45. Gibril F, Chen YJ, Schrump DS, Vortmeyer A, Zhuang Z, Lubensky IA, et al. Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 2003;88:1066-81.
46. Fukai I, Masaoka A, Fujii Y, Yamakawa Y, Yokoyama T, Murase T, et al. Thymic neuroendocrine tumor (thymic carcinoid): a clinicopathologic study in 15 patients. Ann Thorac Surg 1999;67:208-11.
47. Collins DH, Pugh RGB. Classification and frequency of testicular cancer. Br J Urol 1964;36:1-11.
48. Lemarié E, Assouline P, Diot P, Regnard JF, Levasseur P, Droz JP, et al. Primary mediastinal germ cell tumors. Results of a french study. Chest 1992;102:1477-83.
49. International Germ Cell Collaborative Group. International germ cell consensus classification: prognostic factor-based staging system for metastatique germ cell cancers. J Clin Oncol 1997;15:594-601.
50. Nichols CR, Heerema NA, Palmer C, Loeher PJ, Williams SD, Einhorn LH. Klinefelter's syndrome associated with medastinal germ cell neoplasms. J Clin Oncol 1987;5: 1290-4.
51. Hartmann JT, Nichols CR, Droz JP, Norwich A, Gerl A, Fossa SD, et al. Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumors. J Natl Cancer Inst 2000;92:54-61.
52. Bokemeyer C, Nichols CR, Droz JP, Schmoll HJ, Horwich A, Gerl A, et al. Extragonadal germ cell tumors of the mediastinum and retroperitoneum: results from an international analysis. J Clin Oncol 2002;20:1864-73.
53. Takeda S, Miyoshi S, Ohta M, Minami M, Masaoka A, Matsuda H. Primary germ cell tumors in the mediastinum: a 50-year experience at a single Japanese institution. Cancer 2003;97:367-76.
54. Bokemeyer C, Droz JP, Horwich A, Gerl A, Fossa SD, Beyer J, et al. Extragonadal seminoma: an international multicenter analysis of prognostic factors and long term treatment outcome. Cancer 2001;91:1394-401.
55. Clamon GH. Management of primary mediastinal seminoma. Chest 1983;83:263-7.
56. Fizazi K, Culine S, Droz JP, Terrier-Lacombe MJ, Theodore C, Wibault P, et al. Initial management of primary mediastinal seminoma: radiotherapy or cisplatin-based chemotherapy? Eur J Cancer 1998;34:347-52.
57. Sterchi M, Cordell AR. Seminoma of the anterior mediastinum. Ann Thorac Surg 1975;19:371-7.
58. Gerl A, Clemm C, Lamerz R, Wilmanns W. Cisplatin-based chemotherapy of primary extragonadal germ cell tumors. A single institution experience. Cancer 1996;77:526-32.
59. Giaccone G. Multimodality treatment of malignant germ cell tumours of the mediastinum. Eur J Cancer 1991 ;27: 273-7.
60. Gutierrez Delgado F, Tjulandin SA, Garin AM. Long-term results of treatment in patients with extragonadal germ cell tumours. Eur J Cancer 1993;29:1002-5.
61. Childs WJ, Goldstraw P, Nicholls JE, Dearnaley DP, Horwich A. Primary malignant mediastinal germ cell tumours: improved prognosis with platinum-based chemotherapy and surgery. Br J Cancer 1993;67:1098-101.
62. International Germ Cell Consensus Classification. A prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol 1997;15:594-603.
63. Walsh GL, Taylor GD, Nesbitt JC, Amato RJ. Intensive chemotherapy and radical resections for primary nonseminomatous mediastinal germ cell tumors. Ann Thorac Surg 2000;69:337-43.
64. Motzer RJ, Mazumdar M, Gulati SC, Bajorin DF, Lyn P, Vlamis V, et al. Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors. J Natl Cancer Inst 1993;85:1828-35.
65. Ganjoo KN, Rieger KM, Kesler KA, Sharma M, Heilman DK, Einhorn LH. Results of modern therapy for patients with mediastinal nonseminomatous germ cell tumors. Cancer 2000;88:1051-6.
66. Kesler KA, Rieger KM, Ganjoo KN, Sharma M, Fineberg NS, Einhorn LH, et al. Primary mediastinal nonseminomatous germ cell tumors: The Influence of postchemotherapy pathology on long-term survival after surgery. J Thorac Cardiovasc Surg 1999;118:692-700.
67. Nichols CR, Saxman S, Williams SD, Loehrer PJ, Miller ME, Wright C, et al. Primary mediastinal nonseminomatous germ cell tumors. A modern single institution experience. Cancer 1990;65:1641-6.
68. Fizazi K, Culine S, Droz JP, Kramar A, Theodore C, Ruffie P, et al. Primary mediastinal nonseminomatous germ cell tumors: results of modern therapy including cisplatinbased chemotherapy. J Clin Oncol 1998;16:725-32.
69. Rios Zambudio A, Torres Lanzas J, Galindo Fernandez PJ, Roca Calvo MJ, Parilla Paricio P. Hodgkin disease of thymic origin. J Thorac Cardiovasc Surg 2002;123:1208-10.
70. Keller AR, Castleman B. Hodgkin's disease of the thymus gland. Cancer 1974;33:1615-23.
71. Barth TF, Leithauser F, Joos S, Bentz M, Moller P. Mediastinal (thymic) large B-cell lymphoma: where do we stand? Lancet Oncol 2002;3:229-34.
72. Weihrauch MR, Re D, Scheidhauer K, Ansen S, Dietlein M, Bischoff S, et al. Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease. Blood 2001;98:2930-4.
73. Zinzani PL, Martelli M, Magagnoli M, Pescarmona E, Scaramucci L, Palombi F, et al. Treatment and clinical management of primary mediastinal large B-cell lymphoma with sclerosis: MACOP-B regimen and mediastinal radiotherapy monitored by (67)Gallium scan in 50 patients. Blood 1999; 94:3289-93.
74. Zinzani PL, Martelli M, Bertini M, Gianni AM, Devizzi L, Federico M, et al., International Extranodal Lymphoma Study Group (IELSG). Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patients. Haemotologica 2002;87:1258-64.
75. Takeda S, Miyoshi S, Minami M, Ohta M, Masaoka A, Matsuda H. Clinical spectrum of mediastinal cysts. Chest 2003; 124:125-32.
76. Graeber GM, Thompson LD, Cohen DJ, Ronnigen LD, Jaffin J, Zajtchuk R. Cystic lesion of the thymus. An occasionally malignant cervical and/or anterior mediastinal mass. J Thorac Cardiovasc Surg 1984;87:295-300.